cjc ipamorelin 2000mcg CJC-1295 + cjc ipamorelin 2000mcg CJC 1295

Its not a medication, and its not approved for human or animal use outside of authorized studies CJC-1295 (No DAC) is a synthetic GHRH analog without Drug Affinity Complex (DAC), supplied for in-vitro research into growth-hormone signaling pathways, pulsatile secretion dynamics, and peptide-mediated endocrine communication

Optionally, to ensure complete regeneration of the column, 1 mL of 0.5 M NaOH was applied, followed by rinsing with water and reequilibration with chromatography buffer

It works by signaling the pituitary gland to release growth hormone (GH), and its shorter active window compared to DAC versions allows researchers to study more controlled, time-limited GH release patterns

Human studies also confirmed it needs intact GHRH signaling for a maximal pulse, which is why stacks exist

Additionally, IGF-1 indirectly improves insulin sensitivity by suppressing growth hormone (GH) secretion through negative feedback mechanisms